揭开EMBELIN载荷纳米配方的潜力:一个全面的审查
Layba Noor1, Abdul Hafeez2, Md Azizur Rahman1
1Faculty of Pharmacy, Integral University, Lucknow, 226026, India.
AAPS PharmSciTech
|October 21, 2024
概括
恩贝林 (EMB) 是一种天然的抗炎和抗癌化合物,面临着生物可用性挑战. 纳米配方显著提高了它对各种疾病的治疗潜力.
科学领域:
- 自然产品化学 自然产品化学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 植物成分提供了更安全的治疗替代品,改善了患者的遵守.
- 源自Embelia肋骨的Embelin (EMB) 具有强大的抗炎和抗癌特性.
- 低水溶性和低口服生物可用性限制了Embelin的临床效用.
研究的目的:
- 审查Embelin纳米配方,以提高治疗疗效.
- 分析各种纳米载体系统和Embelin的制备方法.
- 讨论基于Embelin的纳米药物的物理化学和临床前潜力.
主要方法:
- 对Embelin纳米配方进行了全面的文献搜索.
- 对纳米载体类型的分析,包括脂质体,纳米颗粒和小粒.
- 评估制备技术,如薄膜水化和纳米沉等.
主要成果:
- 不同的纳米配方 (50-345nm) 改善了Embelin的特性.
- 详细讨论药物捕获,释放和体内研究.
- 探索用于临床翻译的双药方法和专利格局.
结论:
- 纳米封装对于克服Embelin的局限性至关重要.
- 恩贝林纳米配方在治疗炎症和癌症方面显著有前途.
- 需要进一步研究和临床翻译Embelin纳米药物.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.9K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.9K
Bioavailability Enhancement: Drug Solubility Enhancement
504
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
504
Bioavailability Enhancement: Drug Permeability Enhancement
358
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
358
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


